Zydus in-licenses a critical drug for CKD patients from Pharmacosmos of Denmark 09 September 2022

Zydus Cadila’s Sitagliptin Base Tablets Receives Tentative Approval from FDA 06 September 2021 Source link

Zydus Cadila receives tentative approval from USFDA for Brexpiprazole Tablets 09 September 2021 Source link

Zydus Cadila receives final approval from USFDA for Vortioxetine Tablets 18 September 2021 Source link

Zydus Cadila receives final approval from USFDA for Apremilast Tablets 24 September 2021 Source link

Zydus announces positive Phase 2 Proof-of-Concept of NLRP3 inhibitor, ZYIL1 in patients with Cryopyrin Associated Periodic Syndrome (CAPS) 07 September...

Zydus receives final approval and 180 days shared exclusivity from the USFDA for Cariprazine Capsules 12 September 2022 Source link